APA

Chan S., Han K., Qu R., Tong L., Li Y., Zhang Z., Cheng H., Lu X., Patterson A., Smaill J., Ren X., Ding J., Xie H. & Ding K. (20160524). 2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L⁸⁵⁸R/T⁷⁹⁰M). : Bioorganic & medicinal chemistry letters.

Chicago

Chan Shingpan, Han Kun, Qu Rong, Tong Linjiang, Li Yingjun, Zhang Zhang, Cheng Huimin, Lu Xiaoyun, Patterson Adam, Smaill Jeff, Ren Xiaomei, Ding Jian, Xie Hua and Ding Ke. 20160524. 2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L⁸⁵⁸R/T⁷⁹⁰M). : Bioorganic & medicinal chemistry letters.

Harvard

Chan S., Han K., Qu R., Tong L., Li Y., Zhang Z., Cheng H., Lu X., Patterson A., Smaill J., Ren X., Ding J., Xie H. and Ding K. (20160524). 2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L⁸⁵⁸R/T⁷⁹⁰M). : Bioorganic & medicinal chemistry letters.

MLA

Chan Shingpan, Han Kun, Qu Rong, Tong Linjiang, Li Yingjun, Zhang Zhang, Cheng Huimin, Lu Xiaoyun, Patterson Adam, Smaill Jeff, Ren Xiaomei, Ding Jian, Xie Hua and Ding Ke. 2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L⁸⁵⁸R/T⁷⁹⁰M). : Bioorganic & medicinal chemistry letters. 20160524.